Sabrina Y Camp1,2, Eric Kofman1,2, Brendan Reardon1,2, Nathanael D Moore3, Abdullah M Al-Rubaish4, Mohammed Aljumaan4, Amein K Al-Ali4, Eliezer M Van Allen1,2, Amaro Taylor-Weiner5, Saud H AlDubayan6,7,8,9. 1. Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. 2. Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA. 3. Internal Medicine Residency Program, University of Cincinnati, Cincinnati, OH, USA. 4. College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia. 5. Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA. amaro.taylor@gmail.com. 6. Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. SAUD_ALDUBAYAN@DFCI.HARVARD.EDU. 7. Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA. SAUD_ALDUBAYAN@DFCI.HARVARD.EDU. 8. Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA. SAUD_ALDUBAYAN@DFCI.HARVARD.EDU. 9. College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia. SAUD_ALDUBAYAN@DFCI.HARVARD.EDU.
Abstract
PURPOSE: Cohort-based germline variant characterization is the standard approach for pathogenic variant discovery in clinical and research samples. However, the impact of cohort size on the molecular diagnostic yield of joint genotyping is largely unknown. METHODS: Head-to-head comparison of the molecular diagnostic yield of joint genotyping in two cohorts of 239 cancer patients in the absence and then in the presence of 100 additional germline exomes. RESULTS: In 239 testicular cancer patients, 4 (7.4%, 95% confidence interval [CI]: 2.1-17.9) of 54 pathogenic variants in the cancer predisposition and American College of Medical Genetics and Genomics (ACMG) genes were missed by one or both computational runs of joint genotyping. Similarly, 8 (12.1%, 95% CI: 5.4-22.5) of 66 pathogenic variants in these genes were undetected by joint genotyping in another independent cohort of 239 breast cancer patients. An exome-wide analysis of putative loss-of-function (pLOF) variants in the testicular cancer cohort showed that 162 (8.2%, 95% CI: 7.1-9.6) pLOF variants were only detected in one analysis run but not the other, while 433 (22.0%, 95% CI: 20.2-23.9%) pLOF variants were filtered out by both analyses despite having sufficient sequencing coverage. CONCLUSION: Our analysis of the standard germline variant detection method highlighted a substantial impact of concurrently analyzing additional genomic data sets on the ability to detect clinically relevant germline pathogenic variants.
PURPOSE: Cohort-based germline variant characterization is the standard approach for pathogenic variant discovery in clinical and research samples. However, the impact of cohort size on the molecular diagnostic yield of joint genotyping is largely unknown. METHODS: Head-to-head comparison of the molecular diagnostic yield of joint genotyping in two cohorts of 239 cancer patients in the absence and then in the presence of 100 additional germline exomes. RESULTS: In 239 testicular cancer patients, 4 (7.4%, 95% confidence interval [CI]: 2.1-17.9) of 54 pathogenic variants in the cancer predisposition and American College of Medical Genetics and Genomics (ACMG) genes were missed by one or both computational runs of joint genotyping. Similarly, 8 (12.1%, 95% CI: 5.4-22.5) of 66 pathogenic variants in these genes were undetected by joint genotyping in another independent cohort of 239 breast cancer patients. An exome-wide analysis of putative loss-of-function (pLOF) variants in the testicular cancer cohort showed that 162 (8.2%, 95% CI: 7.1-9.6) pLOF variants were only detected in one analysis run but not the other, while 433 (22.0%, 95% CI: 20.2-23.9%) pLOF variants were filtered out by both analyses despite having sufficient sequencing coverage. CONCLUSION: Our analysis of the standard germline variant detection method highlighted a substantial impact of concurrently analyzing additional genomic data sets on the ability to detect clinically relevant germline pathogenic variants.
Authors: Amaro Taylor-Weiner; Travis Zack; Elizabeth O'Donnell; Jennifer L Guerriero; Brandon Bernard; Anita Reddy; G Celine Han; Saud AlDubayan; Ali Amin-Mansour; Steven E Schumacher; Kevin Litchfield; Clare Turnbull; Stacey Gabriel; Rameen Beroukhim; Gad Getz; Scott L Carter; Michelle S Hirsch; Anthony Letai; Christopher Sweeney; Eliezer M Van Allen Journal: Nature Date: 2016-11-30 Impact factor: 49.962
Authors: James T Robinson; Helga Thorvaldsdóttir; Aaron M Wenger; Ahmet Zehir; Jill P Mesirov Journal: Cancer Res Date: 2017-11-01 Impact factor: 12.701
Authors: Ryan Poplin; Pi-Chuan Chang; David Alexander; Scott Schwartz; Thomas Colthurst; Alexander Ku; Dan Newburger; Jojo Dijamco; Nam Nguyen; Pegah T Afshar; Sam S Gross; Lizzie Dorfman; Cory Y McLean; Mark A DePristo Journal: Nat Biotechnol Date: 2018-09-24 Impact factor: 54.908
Authors: Ryan E Mills; W Stephen Pittard; Julienne M Mullaney; Umar Farooq; Todd H Creasy; Anup A Mahurkar; David M Kemeza; Daniel S Strassler; Chris P Ponting; Caleb Webber; Scott E Devine Journal: Genome Res Date: 2011-04-01 Impact factor: 9.043
Authors: Mark A DePristo; Eric Banks; Ryan Poplin; Kiran V Garimella; Jared R Maguire; Christopher Hartl; Anthony A Philippakis; Guillermo del Angel; Manuel A Rivas; Matt Hanna; Aaron McKenna; Tim J Fennell; Andrew M Kernytsky; Andrey Y Sivachenko; Kristian Cibulskis; Stacey B Gabriel; David Altshuler; Mark J Daly Journal: Nat Genet Date: 2011-04-10 Impact factor: 38.330
Authors: Saud H AlDubayan; Louise C Pyle; Marija Gamulin; Tomislav Kulis; Nathanael D Moore; Amaro Taylor-Weiner; Anis A Hamid; Brendan Reardon; Bradley Wubbenhorst; Rama Godse; David J Vaughn; Linda A Jacobs; Stefanie Meien; Mislav Grgic; Zeljko Kastelan; Sarah C Markt; Scott M Damrauer; Daniel J Rader; Rachel L Kember; Jennifer T Loud; Peter A Kanetsky; Mark H Greene; Christopher J Sweeney; Christian Kubisch; Katherine L Nathanson; Eliezer M Van Allen; Douglas R Stewart; Davor Lessel Journal: JAMA Oncol Date: 2019-04-01 Impact factor: 33.006
Authors: Kevin Litchfield; Brenda Summersgill; Shawn Yost; Razvan Sultana; Karim Labreche; Darshna Dudakia; Anthony Renwick; Sheila Seal; Reem Al-Saadi; Peter Broderick; Nicholas C Turner; Richard S Houlston; Robert Huddart; Janet Shipley; Clare Turnbull Journal: Nat Commun Date: 2015-01-22 Impact factor: 14.919
Authors: Adam Auton; Lisa D Brooks; Richard M Durbin; Erik P Garrison; Hyun Min Kang; Jan O Korbel; Jonathan L Marchini; Shane McCarthy; Gil A McVean; Gonçalo R Abecasis Journal: Nature Date: 2015-10-01 Impact factor: 49.962
Authors: Monkol Lek; Konrad J Karczewski; Eric V Minikel; Kaitlin E Samocha; Eric Banks; Timothy Fennell; Anne H O'Donnell-Luria; James S Ware; Andrew J Hill; Beryl B Cummings; Taru Tukiainen; Daniel P Birnbaum; Jack A Kosmicki; Laramie E Duncan; Karol Estrada; Fengmei Zhao; James Zou; Emma Pierce-Hoffman; Joanne Berghout; David N Cooper; Nicole Deflaux; Mark DePristo; Ron Do; Jason Flannick; Menachem Fromer; Laura Gauthier; Jackie Goldstein; Namrata Gupta; Daniel Howrigan; Adam Kiezun; Mitja I Kurki; Ami Levy Moonshine; Pradeep Natarajan; Lorena Orozco; Gina M Peloso; Ryan Poplin; Manuel A Rivas; Valentin Ruano-Rubio; Samuel A Rose; Douglas M Ruderfer; Khalid Shakir; Peter D Stenson; Christine Stevens; Brett P Thomas; Grace Tiao; Maria T Tusie-Luna; Ben Weisburd; Hong-Hee Won; Dongmei Yu; David M Altshuler; Diego Ardissino; Michael Boehnke; John Danesh; Stacey Donnelly; Roberto Elosua; Jose C Florez; Stacey B Gabriel; Gad Getz; Stephen J Glatt; Christina M Hultman; Sekar Kathiresan; Markku Laakso; Steven McCarroll; Mark I McCarthy; Dermot McGovern; Ruth McPherson; Benjamin M Neale; Aarno Palotie; Shaun M Purcell; Danish Saleheen; Jeremiah M Scharf; Pamela Sklar; Patrick F Sullivan; Jaakko Tuomilehto; Ming T Tsuang; Hugh C Watkins; James G Wilson; Mark J Daly; Daniel G MacArthur Journal: Nature Date: 2016-08-18 Impact factor: 49.962
Authors: Konrad J Karczewski; Laurent C Francioli; Grace Tiao; Beryl B Cummings; Jessica Alföldi; Qingbo Wang; Ryan L Collins; Kristen M Laricchia; Andrea Ganna; Daniel P Birnbaum; Laura D Gauthier; Harrison Brand; Matthew Solomonson; Nicholas A Watts; Daniel Rhodes; Moriel Singer-Berk; Eleina M England; Eleanor G Seaby; Jack A Kosmicki; Raymond K Walters; Katherine Tashman; Yossi Farjoun; Eric Banks; Timothy Poterba; Arcturus Wang; Cotton Seed; Nicola Whiffin; Jessica X Chong; Kaitlin E Samocha; Emma Pierce-Hoffman; Zachary Zappala; Anne H O'Donnell-Luria; Eric Vallabh Minikel; Ben Weisburd; Monkol Lek; James S Ware; Christopher Vittal; Irina M Armean; Louis Bergelson; Kristian Cibulskis; Kristen M Connolly; Miguel Covarrubias; Stacey Donnelly; Steven Ferriera; Stacey Gabriel; Jeff Gentry; Namrata Gupta; Thibault Jeandet; Diane Kaplan; Christopher Llanwarne; Ruchi Munshi; Sam Novod; Nikelle Petrillo; David Roazen; Valentin Ruano-Rubio; Andrea Saltzman; Molly Schleicher; Jose Soto; Kathleen Tibbetts; Charlotte Tolonen; Gordon Wade; Michael E Talkowski; Benjamin M Neale; Mark J Daly; Daniel G MacArthur Journal: Nature Date: 2020-05-27 Impact factor: 69.504
Authors: Riaz Gillani; Sabrina Y Camp; Seunghun Han; Jill K Jones; Hoyin Chu; Schuyler O'Brien; Erin L Young; Lucy Hayes; Gareth Mitchell; Trent Fowler; Alexander Gusev; Junne Kamihara; Katherine A Janeway; Joshua D Schiffman; Brian D Crompton; Saud H AlDubayan; Eliezer M Van Allen Journal: Am J Hum Genet Date: 2022-05-04 Impact factor: 11.043